Literature DB >> 20425611

Adjuvant bisphosphonates in breast cancer: the ABCSG-12 study.

Larry J Suva1.   

Abstract

Entities:  

Year:  2010        PMID： 20425611     DOI： 10.1007/s11914-010-0012-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN： 1544-1873            Impact factor:   5.096


× No keyword cloud information.
  2 in total

1.  Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.

Authors:  Toru Hiraga; Paul J Williams; Akimi Ueda; Daisuke Tamura; Toshiyuki Yoneda
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

2.  Reduction in new metastases in breast cancer with adjuvant clodronate treatment.

Authors:  I J Diel; E F Solomayer; S D Costa; C Gollan; R Goerner; D Wallwiener; M Kaufmann; G Bastert
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245
  2 in total
  4 in total

Review 1.  Bone metastasis: mechanisms and therapeutic opportunities.

Authors:  Larry J Suva; Charity Washam; Richard W Nicholas; Robert J Griffin
Journal:  Nat Rev Endocrinol       Date:  2011-01-04       Impact factor: 43.330

2.  Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.

Authors:  Archana Kamalakar; Manali S Bendre; Charity L Washam; Tristan W Fowler; Adam Carver; Joshua D Dilley; John W Bracey; Nisreen S Akel; Aaron G Margulies; Robert A Skinner; Frances L Swain; William R Hogue; Corey O Montgomery; Parshawn Lahiji; Jacqueline J Maher; Kim E Leitzel; Suhail M Ali; Alan Lipton; Richard W Nicholas; Dana Gaddy; Larry J Suva
Journal:  Bone       Date:  2014-01-28       Impact factor: 4.398

3.  PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.

Authors:  Archana Kamalakar; Charity L Washam; Nisreen S Akel; Bethany J Allen; Diarra K Williams; Frances L Swain; Kim Leitzel; Allan Lipton; Dana Gaddy; Larry J Suva
Journal:  J Bone Miner Res       Date:  2017-04-19       Impact factor: 6.741

4.  Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.

Authors:  Tang Liu; Qing Zhang; Zhengxiao Ouyang; Xiaoning Guo; Xia Chen; Bo Liu; Qiang Zhang; Ziqing Yin; Zanjing Zhai; Xinhua Qu; Xuqiang Liu; Dan Peng; Yi Shen
Journal:  Oncotarget       Date:  2017-12-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.